- Autoimmune hemolytic anemia and pediatric Hodgkin lymphoma: a clinical case
Autoimmune hemolytic anemia and pediatric Hodgkin lymphoma: a clinical case
Modern Pediatrics. Ukraine. (2025).7(151): 102-107. doi: 10.15574/SP.2025.7(151).102107
Makieieva N. I.1, Koval V. A.1, Boldyreva O. S.2, Kucherenko M. V.2, Derkach A. V.2
1Kharkiv National Medical University, Ukraine
2CNE "City Clinical Multidisciplinary Hospital No. 25" of the Kharkiv City Council, Ukraine
For citation: Makieieva NI, Koval VA, Boldyreva OS, Kucherenko MV, Derkach AV. (2025). Autoimmune hemolytic anemia and pediatric Hodgkin lymphoma: a clinical case. Modern Pediatrics. Ukraine. 7(151): 102-107. doi: 10.15574/SP.2025.7(151).102107.
Article received: May 30, 2025. Accepted for publication: Nov 09, 2025.
Autoimmune hemolytic anemia (AIHA) in combination with Hodgkin lymphoma (HL) is a rare occurrence in pediatric practice. AIHA can pose significant diagnostic challenges, masking or diverting clinical attention from the underlying oncological process.
Clinical case. This article presents a case of an 11-year-old boy diagnosed with both AIHA and HL. Initially, the patient was diagnosed with AIHA; however, further evaluation revealed the presence of HL. Standard therapy for AIHA proved to be ineffective, necessitating a change in treatment strategy. Sustained remission was achieved only after protocol-based combination chemotherapy targeting the primary oncological disease.
The article also includes a review of current scientific literature regarding the coexistence of AIHA and HL. Analysis of published clinical cases helps to better understand the pathogenetic mechanisms, diagnostic difficulties, and therapeutic approaches in such rare presentations.
Conclusions. This case emphasizes the importance of early recognition of the oncohematological nature of AIHA in pediatric patients. Further research is needed to improve our understanding of the immunopathogenesis of AIHA in the context of HL, which will support the development of better treatment strategies and improve patient outcomes.
The study was carried out according to the principles of the Declaration of Helsinki. Agreement of parents was obtained for the study.
Authors declare no conflict of interest.
Keywords: autoimmune hemolytic anemia, Hodgkin lymphoma, children, case report, autoimmune mechanisms, oncohematology.
REFERENCE
1. Ansell SM. (2016). Hodgkin lymphoma: 2016 update on diagnosis, risk stratification, and management. American Journal of Hematology. 91: 434-442. https://doi.org/10.1002/ajh.24272; PMid:27001163
2. Bowdler AJ, Glick IW. (1966). Autoimmune hemolytic anemia as the herald state of Hodgkin's disease. Annals of Internal Medicine. 65(4): 761-767. https://doi.org/10.7326/0003-4819-65-4-761; PMid:5926396
3. Burley NB, Dy PS, Hande S, Kalantri S, Mohindroo C, Miller K. (2021). Autoimmune Hemolytic Anemia as Presenting Symptom of Hodgkin Lymphoma. Case Reports in Hematology. 2021: 5580823. https://doi.org/10.1155/2021/5580823; PMid:33859850 PMCid:PMC8026303
4. Dimou M, Angelopoulou MK, Pangalis GA, Georgiou G, Kalpadakis C et al. (2012). Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma. Leukemia & Lymphoma. 53(8): 1481-1487. https://doi.org/10.3109/10428194.2012.660628; PMid:22280533
5. Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. (2001). The dual association between lymphoma and autoimmunity. Blood Cells, Molecules, and Diseases. 27(4): 750-756. https://doi.org/10.1006/bcmd.2001.0442; PMid:11778659
6. Feng Q, Zak D, Daya R. (2012). Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review. Clinical Advances in Hematology & Oncology. 10(4): 270-276.
7. Fraint E, Guo X, Gavrilova T. (2021). Isolated B-cell lymphopenia and autoimmune hemolytic anemia as a curious combination of findings at the time of advanced Hodgkin lymphoma diagnosis: a pediatric case report. AME Case Reports. 5: 26. https://doi.org/10.21037/acr-21-16; PMid:34312605 PMCid:PMC8256115
8. Goldin LR, Landgren O. (2009). Autoimmunity and lymphomagenesis. International Journal of Cancer. 124(7): 1497-1502. https://doi.org/10.1002/ijc.24141; PMid:19089924 PMCid:PMC2666348
9. Gomes MM, Oliva T, Pinto A. (2016). Autoimmune Hemolytic Anemia and Hodgkin's Disease: An Unusual Pediatric Association. Case Reports in Pediatrics. 2016: 4598587. https://doi.org/10.1155/2016/4598587; PMid:26904342 PMCid:PMC4745911
10. Goodnow CC. (2007). Multistep pathogenesis of autoimmune disease. Cell. 130(1): 25-35. https://doi.org/10.1016/j.cell.2007.06.033; PMid:17632054
11. Kar S, Kumar CGD, Kar R, Basavarajegowda A. (2024). Autoimmune Hemolytic Anemia in Children: Clinical Profile and Outcome. Indian Journal of Pediatrics. 91(2): 143-148. https://doi.org/10.1007/s12098-022-04469-6; PMid:36787020
12. Levine AM, Thornton P, Forman SJ, Van Hale P, Holdorf D, Rouault CL et al. (1980). Positive Coombs test in Hodgkin's disease: significance and implications. Blood. 55(4): 607-611. https://doi.org/10.1182/blood.V55.4.607.607; PMid:7357087
13. Majumdar G. (1995). Unremitting severe autoimmune haemolytic anaemia as a presenting feature of Hodgkin's disease with minimum tumour load. Leukemia & Lymphoma. 20(1-2): 169-172. https://doi.org/10.3109/10428199509054771; PMid:8750641
14. National Cancer Institute. (n.d.). NCCR Explorer: An interactive website for NCCR cancer statistics. Bethesda, MD: National Cancer Institute. Available online. Last accessed February 25, 2025.
15. Ozdemir F, Yilmaz M, Akdogan R, Kaynar K, Kavgaci H, Karti S, Aydin F. (2005). Hodgkin's disease and autoimmune hemolytic anemia: a case report. Medical Principles and Practice. 14(3): 205-207. https://doi.org/10.1159/000084642; PMid:15863998
16. Roumier M, Loustau V, Guillaud C, Languille L, Mahevas M, Khellaf M et al. (2014). Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients. American Journal of Hematology. 89(9): E150-E155. https://doi.org/10.1002/ajh.23767; PMid:24847759
17. Sallah S, Wan JY, Hanrahan LR. (2001). Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia. Clinical Cancer Research. 7(4): 791-794.
18. Sengottaiyan J, Jayaraman D, Kumar S, Shanmugam SG, Scott JX. (2024). Autoimmune Hemolytic Anemia as Paraneoplastic Phenomenon in Hodgkins Lymphoma in Children – A Rare Occurrence. EJIFCC. 35(1): 52-54.
19. Shah MB, Nanjapp V, Devaraj HS, Sindhu KS. (2013). Autoimmune hemolytic anaemia in Hodgkin's lymphoma. Journal of the Association of Physicians of India. 61(7): 492-494.
20. Shah SS, Khubchandani SR, Parikh RS et al. (2017). Autoimmune hemolytic anemia in Hodgkin's lymphoma: a case report. Hematology & Transfusion International Journal. 4(6): 145-147. https://doi.org/10.15406/htij.2017.04.00101
21. Sierra RD. (1991). Coombs-positive hemolytic anemia in Hodgkin's disease: case presentation and review of the literature. Military Medicine. 156(12): 691-692. https://doi.org/10.1093/milmed/156.12.691; PMid:1780074
22. Smith MA, Altekruse SF, Adamson PC et al. (2014). Declining childhood and adolescent cancer mortality. Cancer. 120(16): 2497-2506. https://doi.org/10.1002/cncr.28748; PMid:24853691 PMCid:PMC4136455
23. Sokol RJ, Booker DJ, Stamps R. (1994). Erythrocyte autoantibodies, autoimmune haemolysis, and carcinoma. Journal of Clinical Pathology. 47(4): 340-343. https://doi.org/10.1136/jcp.47.4.340; PMid:8027372 PMCid:PMC501938
